Increased serum levels of fibrinogen degradation products due to treatment with recombinant tissue-type plasminogen activator for acute myocardial infarction are related to bleeding complications, but not to coronary patency-Reference-Cited by-同舟云学术

Increased serum levels of fibrinogen degradation products due to treatment with recombinant tissue-type plasminogen activator for acute myocardial infarction are related to bleeding complications, but not to coronary patency

Published:1989-09 Issue:3 Volume:14 Page:581-588
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Arnold Alfred E.R.,Brower Ronald W.,Collen Desire,van Es Gerrit-Anne,Lubsen Jacobus,Serruys Patrick W.,Simoons Maarten L.,Verstraete Marc

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference24 articles.

1. Thrombolysis in Myocardial Infarction (TIM I) Trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase;Chesebro;Circulation,1987

2. Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction.;Verstraete;Lancet,1985

3. Effect of intravenous tissue plasminogen activator on infarct size, left ventricular function and survival in patients with acute myocardial infarction;Van de Werf;Br Med J,1988

4. Coronary thrombolysis and myocardial salvage by tissue plasminogen activator given up to 4 hours after onset of myocardial infarction;National Heart Foundation of Australia;Lancet,1988

5. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction (ASSET);Wilcox;Lancet,1988

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Vitro Examination of the Thrombolytic Efficacy of Desmoteplase and Therapeutic Ultrasound Compared with rt-PA;Ultrasound in Medicine & Biology;2015-12

2. Aortic Transgraft Hemorrhage after Intravenous Tissue Plasminogen Activator Therapy in Patients with Acute Ischemic Stroke;Journal of Stroke and Cerebrovascular Diseases;2014-09

3. The use of desmoteplase (bat saliva) in the treatment of ischaemia;Expert Opinion on Biological Therapy;2013-02-11

4. Desmoteplase;Expert Opinion on Biological Therapy;2009-05-20

5. Incorporation of Fragment X into Fibrin Clots Renders Them More Susceptible to Lysis by Plasmin;Biochemistry;2006-03-14